139 related articles for article (PubMed ID: 27766186)
1. Prediction of positron emission tomography/computed tomography (PET/CT) positivity in patients with high-risk primary melanoma.
Danielsen M; Kjaer A; Wu M; Martineau L; Nosrati M; Leong SP; Sagebiel RW; Miller JR; Kashani-Sabet M
Am J Nucl Med Mol Imaging; 2016; 6(5):277-285. PubMed ID: 27766186
[TBL] [Abstract][Full Text] [Related]
2. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
3. Inefficacy of F-18 fluorodeoxy-D-glucose-positron emission tomography scans for initial evaluation in early-stage cutaneous melanoma.
Wagner JD; Schauwecker D; Davidson D; Logan T; Coleman JJ; Hutchins G; Love C; Wenck S; Daggy J
Cancer; 2005 Aug; 104(3):570-9. PubMed ID: 15977211
[TBL] [Abstract][Full Text] [Related]
4. Role of
Malik D; Sood A; Mittal BR; Basher RK; Bhattacharya A; Singh G
World J Nucl Med; 2019; 18(2):176-182. PubMed ID: 31040750
[TBL] [Abstract][Full Text] [Related]
5. [The role of preoperative (18)F-FDG PET-CT in lymphatic metastasis diagnosis of cutaneous malignant melanoma on extremities and trunk].
Zhang XX; Fang Y; Xu LB; Xu SF; Zhao ZG; Sun C; Ma PQ; Liu T; Yu SJ; Zhang WJ
Zhonghua Zhong Liu Za Zhi; 2018 May; 40(5):372-378. PubMed ID: 29860765
[No Abstract] [Full Text] [Related]
6. Whole-body
Gajjala SR; Hulikal N; Kadiyala S; Kottu R; Kalawat T
Indian J Med Res; 2018 Mar; 147(3):256-262. PubMed ID: 29923514
[TBL] [Abstract][Full Text] [Related]
7. Impact of (18)f-fluorodeoxyglucose positron emission tomography/computed tomography scan on initial evaluation of head and neck squamous cell carcinoma: our experience at a tertiary care center in India.
Nair S; Mohan S; Nilakantan A; Gupta A; Malik A; Gupta A
World J Nucl Med; 2015; 14(1):19-24. PubMed ID: 25709540
[TBL] [Abstract][Full Text] [Related]
8. Staging Uveal Melanoma with Whole-Body Positron-Emission Tomography/Computed Tomography and Abdominal Ultrasound: Low Incidence of Metastatic Disease, High Incidence of Second Primary Cancers.
Cohen VML; Pavlidou E; DaCosta J; Arora AK; Szyszko T; Sagoo MS; Szlosarek P
Middle East Afr J Ophthalmol; 2018; 25(2):91-95. PubMed ID: 30122854
[TBL] [Abstract][Full Text] [Related]
9. Whole-body F-18-fluoro-2-deoxyglucose positron emission tomography/computed tomography imaging in the follow-up of metastatic uveal melanoma.
Klingenstein A; Haug AR; Nentwich MM; Tiling R; Schaller UC
Melanoma Res; 2010 Dec; 20(6):511-6. PubMed ID: 20890225
[TBL] [Abstract][Full Text] [Related]
10. Role of FDG-PET in the assessment of survival prognosis in melanoma.
Pleiss C; Risse JH; Biersack HJ; Bender H
Cancer Biother Radiopharm; 2007 Dec; 22(6):740-7. PubMed ID: 18158764
[TBL] [Abstract][Full Text] [Related]
11. Occult mediastinal lymph node metastasis in NSCLC patients diagnosed as clinical N0-1 by preoperative integrated FDG-PET/CT and CT: Risk factors, pattern, and histopathological study.
Kanzaki R; Higashiyama M; Fujiwara A; Tokunaga T; Maeda J; Okami J; Kozuka T; Hosoki T; Hasegawa Y; Takami M; Tomita Y; Kodama K
Lung Cancer; 2011 Mar; 71(3):333-7. PubMed ID: 20619479
[TBL] [Abstract][Full Text] [Related]
12. FDG PET in early stage cutaneous malignant melanoma.
McIvor J; Siew T; Campbell A; McCarthy M
J Med Imaging Radiat Oncol; 2014 Apr; 58(2):149-54; quiz 266. PubMed ID: 24690243
[TBL] [Abstract][Full Text] [Related]
13. Clinical value of whole body
Bower N; Morris A; O'Connor J; Sponagle M; Bahr R; Gilbert R; Mohamed A; Bower J
J Med Imaging Radiat Sci; 2024 Jun; 55(2):212-220. PubMed ID: 38403520
[TBL] [Abstract][Full Text] [Related]
14. Whole-body
Ren YY; Li YC; Wu HB; Wang QS; Han YJ; Zhou WL; Li HS
Eur J Radiol; 2017 Apr; 89():200-207. PubMed ID: 28267540
[TBL] [Abstract][Full Text] [Related]
15. Routine FDG PET-CT in patients with a high-risk localized melanoma has a high predictive positive value for nodal disease and high negative predictive value for the presence of distant metastases.
Wagner T; Chevreau C; Meyer N; Mourey L; Courbon F; Zerdoud S
J Eur Acad Dermatol Venereol; 2012 Nov; 26(11):1431-5. PubMed ID: 22017492
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic imaging in dermatology: utility of PET-CT in cutaneous melanoma.
Sánchez-Sánchez R; Serrano-Falcón C; Rebollo Aguirre AC
Actas Dermosifiliogr; 2015; 106(1):29-34. PubMed ID: 24661948
[TBL] [Abstract][Full Text] [Related]
17. Capsule endoscopy versus positron emission tomography for detection of small-bowel metastatic melanoma: a pilot study.
Prakoso E; Fulham M; Thompson JF; Selby WS
Gastrointest Endosc; 2011 Apr; 73(4):750-6. PubMed ID: 21288518
[TBL] [Abstract][Full Text] [Related]
18. Breslow thickness and (18)F-FDG PET-CT result in initial staging of cutaneous melanoma: Can a cut-off point be established?
Ortega-Candil A; Rodríguez-Rey C; Cano-Carrizal R; Cala-Zuluaga E; González Larriba JL; Jiménez-Ballvé A; Fuentes-Ferrer ME; Cabrera-Martín MN; Pérez-Castejón MJ; García García-Esquinas M; Lapeña-Gutierrez L; Carreras-Delgado JL
Rev Esp Med Nucl Imagen Mol; 2016; 35(2):96-101. PubMed ID: 26597332
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness of adding FDG-PET or CT to the diagnostic work-up of patients with stage III melanoma.
Bastiaannet E; Uyl-de Groot CA; Brouwers AH; van der Jagt EJ; Hoekstra OS; Oyen W; Verzijlbergen F; van Ooijen B; Thompson JF; Hoekstra HJ
Ann Surg; 2012 Apr; 255(4):771-6. PubMed ID: 22367443
[TBL] [Abstract][Full Text] [Related]
20. Can integrated 18F-FDG PET/MR replace sentinel lymph node resection in malignant melanoma?
Schaarschmidt BM; Grueneisen J; Stebner V; Klode J; Stoffels I; Umutlu L; Schadendorf D; Heusch P; Antoch G; Pöppel TD
Eur J Nucl Med Mol Imaging; 2018 Nov; 45(12):2093-2102. PubMed ID: 29876618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
